NMPA Approval

Ceftriaxone Sodium and Tazobactam Sodium for Injection

Approval Number

国药准字H20227152

Company南京优科制药有限公司

Registration Date

November 2, 2022

Previous Approval Numbers

国药准字H20193411

Drug Information

Generic Name

注射用头孢曲松钠他唑巴坦钠

Dosage Form

注射剂

Strength

2.0g（C₁₈H₁₈N₈O₇S₃ 1.5g与C₁₀H₁₂N₄O₅S 0.5g）

Drug Type

化学药品

Registration Date

November 2, 2022

Company Information

Applicant Company

Company Name南京优科制药有限公司

Manufacturing Company

Company Name南京优科制药有限公司

Company Address

南京经济技术开发区恒竞路28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用头孢曲松钠他唑巴坦钠 - NMPA 批准文号 | MedPath